Jiannis Ragoussis - Genetic Mutations

Author Information

Jiannis Ragoussis is affiliated with the McGill Genome Centre, Department of Human Genetics, McGill University, located in Montréal, Québec, Canada. His research focuses on various aspects of genetics and genomics, with a particular interest in transcriptomics, cancer genomics, and the genetic basis of diseases.

Research Contributions

Jiannis Ragoussis has made significant contributions to the field of genetics through his extensive research on various topics. His recent work in 2022 includes studies on single-cell transcriptomics to identify inflammatory networks in brain endothelium and biomarkers for intervertebral disc degeneration. He has also investigated the detection of SARS-CoV-2 variants, the impact of whole-exome sequencing in ovarian cancer, and the transcriptional landscape of glioblastoma and medulloblastoma. Additionally, his research has delved into the genetic data of individuals from the Canadian Longitudinal Study on Aging and the role of type I IFN immunity genes in COVID-19 severity.

Aliases

Jiannis Ragoussis is also known by the following aliases: J Ragoussis, J. Ragoussis, and Jiannis Ragoussis.

Publication and Citation Metrics

Metric	Value
Citation Count	23,386
h-index	75
Paper Count	356
Affiliation	McGill Genome Centre, Department of Human Genetics, McGill University, Montréal, Québec, Canada

Publications:

Single-Cell Transcriptomics Identifies Brain Endothelium Inflammatory Networks in Experimental Autoimmune Encephalomyelitis

DOI: 10.2139/ssrn.4043094

Year: 2022

Single-Cell RNA-Seq Analysis of Cells from Degenerating and Non-Degenerating Intervertebral Discs from the Same Individual Reveals New Biomarkers for Intervertebral Disc Degeneration

DOI: 10.3390/ijms23073993

Year: 2022

Detection of prevalent SARS-CoV-2 variant lineages in wastewater and clinical sequences from cities in Quebec, Canada

DOI: 10.1101/2022.02.01.22270170

Year: 2022

Case Review: Whole-Exome Sequencing Analyses Identify Carriers of a Known Likely Pathogenic Intronic BRCA1 Variant in Ovarian Cancer Cases Clinically Negative for Pathogenic BRCA1 and BRCA2 Variants

DOI: 10.3390/genes13040697

Year: 2022

Glioblastoma scRNAseq Shows Treatment-induced, Immune-dependent Rise In Mesenchymal Cancer Cells, and Structural Variants in Distal Neural Stem Cells.

DOI: 10.1093/neuonc/noac085

Year: 2022

Single-cell RNA sequencing reveals time- and sex-specific responses of mouse spinal cord microglia to peripheral nerve injury and links ApoE to chronic pain

DOI: 10.1038/s41467-022-28473-8

Year: 2022

Cohort profile: genomic data for 26 622 individuals from the Canadian Longitudinal Study on Aging (CLSA)

DOI: 10.1136/bmjopen-2021-059021

Year: 2022

Long-term tumour dormancy in a BRCA1 heterozygote

DOI: 10.1136/jmedgenet-2021-108269

Year: 2022

Rare loss-of-function variants in type I IFN immunity genes are not associated with severe COVID-19.

DOI: 10.1172/JCI147834

Year: 2021

The transcriptional landscape of Shh medulloblastoma

DOI: 10.1038/s41467-021-21883-0

Year: 2021

How is PCR Used to Detect Genetic Mutations?

What is the Impact of Inherited Mutations?

What are Autism Spectrum Disorders?

How Do Insertion Mutations Occur?

Can Genetic Disorders Affect Child Development?

What are Zinc Finger Nucleases (ZFNs)?

What is Radiation?

How Does Genetic Counseling Help?

What Are Developmental Disorders?

How is Sickle Cell Disease Diagnosed?

Partnered Content Networks

Relevant Topics